Search

Dwight J Klemm

from Highlands Ranch, CO
Age ~63

Dwight Klemm Phones & Addresses

  • 10304 Ravenswood Ln, Littleton, CO 80130 (303) 683-6857
  • Highlands Ranch, CO
  • Aurora, CO
  • South Euclid, OH
  • San Antonio, TX

Work

Company: University of colorado anschutz medical campus Mar 2001 Position: Professor

Education

School / High School: Case Western Reserve University 1988 to 1990 Specialities: Molecular Biology, Biochemistry

Skills

Obesity • Metabolism • Adult Stem Cells • Developmental Cell Biology • Flow Cytometry • Transgenic Mice • Science • Cell Culture • Molecular Biology • Biochemistry • Microscopy • Animal Models • Genetics • Project Management • Grant Writing • Clinical Research • Life Sciences • Research • Western Blotting • Cell Biology

Interests

Science and Technology

Emails

d***y@earthlink.net

Industries

Higher Education

Resumes

Resumes

Dwight Klemm Photo 1

Professor

View page
Location:
13001 east 17Th Pl, Aurora, CO 80045
Industry:
Higher Education
Work:
University of Colorado Anschutz Medical Campus
Professor

National Jewish Health 1990 - 2001
Faculty Member
Education:
Case Western Reserve University 1988 - 1990
The University of New Mexico 1982 - 1986
Doctorates, Doctor of Philosophy, Biochemistry, Philosophy
The University of New Mexico 1978 - 1981
Bachelors, Bachelor of Science, Biology
Skills:
Obesity
Metabolism
Adult Stem Cells
Developmental Cell Biology
Flow Cytometry
Transgenic Mice
Science
Cell Culture
Molecular Biology
Biochemistry
Microscopy
Animal Models
Genetics
Project Management
Grant Writing
Clinical Research
Life Sciences
Research
Western Blotting
Cell Biology
Interests:
Science and Technology

Publications

Us Patents

Method For Modulation Of Cell Phenotype

View page
US Patent:
20040097454, May 20, 2004
Filed:
May 6, 2003
Appl. No.:
10/431598
Inventors:
Jane Reusch - Denver CO, US
Dwight Klemm - Highlands Ranch CO, US
International Classification:
A61K048/00
C12Q001/68
US Classification:
514/044000, 435/006000
Abstract:
Described is a method for modulating the phenotype of a cell, and particularly, of a target cell in a patient who has or is at risk of developing a disease or condition in which is associated with dysregulation of cellular phenotype. The method includes administration of a recombinant nucleic acid molecule encoding a protein having CREB biological activity or dominant negative CREB biological activity to a patient, in such a manner that the protein is expressed in a target cell of a patient and is sufficient to modulate the phenotype of the target cell. Such a method is particularly useful in patients who have, or at risk of developing, diabetes, obesity, macrovascular disease, heart failure, osteoarthritis, and neural diseases and conditions.
Dwight J Klemm from Highlands Ranch, CO, age ~63 Get Report